Product Overview:
This tablet formulation combines Tesofensine for appetite suppression with Mucuna Pruriens for dopamine support and Choline Bitartrate for cognitive enhancement. It is designed to target weight management while supporting neurological health.
 
Research Benefits:
Tesofensine (500 mcg): Reduces hunger while boosting metabolism through neurotransmitter modulation. Clinical trials show dose-dependent weight loss benefits even at lower doses. Support neurotransmitter pathway analysis in preclinical studies.
Mucuna Pruriens (L-DOPA): Enhances dopamine production, improving mood, motor function, and testosterone levels while supporting neurological health in conditions like Parkinson’s disease. Standardized for L-DOPA content.
Choline Bitartrate: Promotes acetylcholine synthesis for cognitive function while supporting liver detoxification and cardiovascular health. A choline source for cellular research.
 
Potential Applications:
Ideal for research exploring holistic approaches to weight management combined with cognitive enhancement or mood stabilization.
 
Value Proposition:
At $2.50 per tablet, this product is highly cost-effective compared to standalone nootropics or adaptogens.
 
 
L-DOPA has potential side effects in research settings.